Journal
TUMOR BIOLOGY
Volume 37, Issue 10, Pages 13885-13892Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-016-5139-2
Keywords
beta 2-adrenergic receptor; Gastric cancer; Prognosis; Immunohistochemistry; beta 2-blocker
Categories
Ask authors/readers for more resources
The beta 2-adrenergic receptor (beta 2-AR) is highly expressed in various human neoplasms and has been considered a novel therapeutic target of cancer treatment. However, the clinicopathological significance of beta 2-AR expression in patients with gastric cancer (GC) remains unclear. The aim of this study was to explore beta 2-AR expression and its prognostic significance. A total of 331 patients with surgically resected GC were evaluated. Tumor sections were stained immunohistochemically for beta 2-AR. And, we confirmed beta 2-AR expression in the GC cell lines by Western blot. beta 2-AR was highly expressed in 30.5 % of GC patients. Expression was significantly associated with age, T factor, tumor differentiation, histology of non-signet cells, lymphatic permeation, and vascular invasion. And, all the GC cell lines expressed beta 2-AR. On univariate analysis, age, disease stage, T factor, N factor, lymphatic permeation, vascular invasion, and beta 2-AR expression were significantly associated with overall survival. Although the multivariate analysis did not indicate that beta 2-AR expression was independently prognostic of survival, high-level beta 2-AR expression was associated with significantly poorer survival of GC patients with well or moderately differentiated tumors. beta 2-AR expression was a significant predictor of tumor aggressiveness in, and poorer survival of, patients with GC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available